Full List of Metabolite(s) Regulated by This Protein |
Nucleosides, nucleotides, and analogues |
3'-AMP |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
3'-AMP concentration: decrease (Log2 FC=0.58) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 3'-AMP levels compared with control group. |
3'-O-Methyladenosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
3'-O-Methyladenosine concentration: increase (Log2 FC=7.29) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 3'-o-methyladenosine levels compared with control group. |
5'-Methylthioadenosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
5'-Methylthioadenosine concentration: decrease (Log2 FC=0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 5'-methylthioadenosine levels compared with control group. |
5,2'-O-Dimethyluridine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
5,2'-O-Dimethyluridine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 5,2'-o-dimethyluridine levels compared with control group. |
5-Thymidylic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
5-Thymidylic acid concentration: decrease (Log2 FC=0.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 5-thymidylic acid levels compared with control group. |
7-Methylguanosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
7-Methylguanosine concentration: increase (Log2 FC=1.2) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 7-methylguanosine levels compared with control group. |
Adenosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Adenosine concentration: increase (Log2 FC=5.97) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of adenosine levels compared with control group. |
ADP |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
ADP concentration: decrease (Log2 FC=0.91) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of ADP levels compared with control group. |
AICA-riboside |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
AICA-riboside concentration: decrease (Log2 FC=0.19) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of AICA-riboside levels compared with control group. |
AICAR |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
AICAR concentration: decrease (Log2 FC=0.27) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of AICAR levels compared with control group. |
Allopurinol riboside |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Allopurinol riboside concentration: increase (Log2 FC=14.06) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of allopurinol riboside levels compared with control group. |
CMP-N-Acetylneuraminate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
CMP-N-Acetylneuraminate concentration: increase (Log2 FC=1.34) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of CMP-N-acetylneuraminate levels compared with control group. |
Cyclic AMP |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Cyclic AMP concentration: increase (Log2 FC=2.45) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of cyclic AMP levels compared with control group. |
Cytidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Cytidine concentration: increase (Log2 FC=7.28) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of cytidine levels compared with control group. |
Cytidine monophosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Cytidine monophosphate concentration: decrease (Log2 FC=0.74) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of cytidine monophosphate levels compared with control group. |
Cytidine-5'-diphosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Cytidine-5'-diphosphate concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of cytidine-5'-diphosphate levels compared with control group. |
Deoxyadenosine monophosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Deoxyadenosine monophosphate concentration: increase (Log2 FC=1.28) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of deoxyadenosine monophosphate levels compared with control group. |
Deoxyguanosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Deoxyguanosine concentration: increase (Log2 FC=2.47) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of deoxyguanosine levels compared with control group. |
Deoxyinosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Deoxyinosine concentration: increase (Log2 FC=2.37) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of deoxyinosine levels compared with control group. |
Deoxyuridine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Deoxyuridine concentration: increase (Log2 FC=3.23) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of deoxyuridine levels compared with control group. |
Dephospho-CoA |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Dephospho-CoA concentration: decrease (Log2 FC=0.58) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of dephospho-CoA levels compared with control group. |
Diadenosine tetraphosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Diadenosine tetraphosphate concentration: increase (Log2 FC=1.1) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of diadenosine tetraphosphate levels compared with control group. |
FAD |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
FAD concentration: decrease (Log2 FC=0.85) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of FAD levels compared with control group. |
Flavin mononucleotide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Flavin mononucleotide concentration: decrease (Log2 FC=0.73) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of flavin mononucleotide levels compared with control group. |
Guanosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Guanosine concentration: increase (Log2 FC=10.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of guanosine levels compared with control group. |
Guanosine diphosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Guanosine diphosphate concentration: increase (Log2 FC=1.28) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of guanosine diphosphate levels compared with control group. |
Guanosine diphosphate mannose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Guanosine diphosphate mannose concentration: decrease (Log2 FC=0.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of guanosine diphosphate mannose levels compared with control group. |
Guanosine monophosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Guanosine monophosphate concentration: decrease (Log2 FC=0.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of guanosine monophosphate levels compared with control group. |
Inosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Inosine concentration: increase (Log2 FC=9.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of inosine levels compared with control group. |
Inosinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Inosinic acid concentration: decrease (Log2 FC=0.74) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of inosinic acid levels compared with control group. |
N2,N2-Dimethylguanosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N2,N2-Dimethylguanosine concentration: decrease (Log2 FC=0.84) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N2,N2-dimethylguanosine levels compared with control group. |
N6-Methyladenosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N6-Methyladenosine concentration: increase (Log2 FC=1.98) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of N6-methyladenosine levels compared with control group. |
NAD |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
NAD concentration: increase (Log2 FC=1.37) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of NAD levels compared with control group. |
NADP |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
NADP concentration: decrease (Log2 FC=0.99) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of NADP levels compared with control group. |
Nicotinamide ribotide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Nicotinamide ribotide concentration: increase (Log2 FC=1.38) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of nicotinamide ribotide levels compared with control group. |
Phosphoadenosine phosphosulfate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phosphoadenosine phosphosulfate concentration: decrease (Log2 FC=0.98) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of phosphoadenosine phosphosulfate levels compared with control group. |
Riboprine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Riboprine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of riboprine levels compared with control group. |
Ribothymidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Ribothymidine concentration: decrease (Log2 FC=0.35) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of ribothymidine levels compared with control group. |
S-Adenosylhomocysteine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
S-Adenosylhomocysteine concentration: increase (Log2 FC=1.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of s-adenosylhomocysteine levels compared with control group. |
S-Adenosylmethionine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
S-Adenosylmethionine concentration: decrease (Log2 FC=0.8) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of s-adenosylmethionine levels compared with control group. |
Thymidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Thymidine concentration: increase (Log2 FC=5.4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of thymidine levels compared with control group. |
UDP glucose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
UDP glucose concentration: decrease (Log2 FC=0.84) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of UDP glucose levels compared with control group. |
UDP-N-acetylglucosamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
UDP-N-acetylglucosamine concentration: increase (Log2 FC=1.05) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of UDP-N-acetylglucosamine levels compared with control group. |
Uridine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Uridine concentration: increase (Log2 FC=1.28) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of uridine levels compared with control group. |
Uridine 5'-diphosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Uridine 5'-diphosphate concentration: decrease (Log2 FC=0.77) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of uridine 5'-diphosphate levels compared with control group. |
Uridine 5'-monophosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Uridine 5'-monophosphate concentration: decrease (Log2 FC=0.38) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of uridine 5'-monophosphate levels compared with control group. |
Uridine diphosphategalactose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Uridine diphosphategalactose concentration: decrease (Log2 FC=0.87) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of uridine diphosphategalactose levels compared with control group. |
Xanthosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Xanthosine concentration: increase (Log2 FC=5.92) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of xanthosine levels compared with control group. |
Benzenoids |
Adenylsuccinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Adenylsuccinic acid concentration: decrease (Log2 FC=0.57) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of adenylsuccinic acid levels compared with control group. |
Dopamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Dopamine concentration: decrease (Log2 FC=0.8) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of dopamine levels compared with control group. |
Lumichrome |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Lumichrome concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of lumichrome levels compared with control group. |
Norepinephrine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Norepinephrine concentration: increase (Log2 FC=1.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of norepinephrine levels compared with control group. |
Phthalic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phthalic acid concentration: decrease (Log2 FC=0.81) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of phthalic acid levels compared with control group. |
Proglumide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Proglumide concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of proglumide levels compared with control group. |
Salicyluric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Salicyluric acid concentration: increase (Log2 FC=1.04) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of salicyluric acid levels compared with control group. |
Tyramine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Tyramine concentration: decrease (Log2 FC=0.79) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of tyramine levels compared with control group. |
Lipid-related molecules |
Erucamide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Erucamide concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of erucamide levels compared with control group. |
Lipids and lipid-like molecules |
(E)-4-Hexen-1-ol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
(E)-4-Hexen-1-ol concentration: increase (Log2 FC=1.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of (E)-4-hexen-1-ol levels compared with control group. |
1-Octadecenoyl-sn-glycero-3-phosphoethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
1-Octadecenoyl-sn-glycero-3-phosphoethanolamine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 1-octadecenoyl-sn-glycero-3-phosphoethanolamine levels compared with control group. |
1-Oleoyl-sn-glycerol 3-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
1-Oleoyl-sn-glycerol 3-phosphate concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 1-oleoyl-sn-glycerol 3-phosphate levels compared with control group. |
2-Methyl-3-hydroxybutyric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
2-Methyl-3-hydroxybutyric acid concentration: increase (Log2 FC=1.08) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 2-methyl-3-hydroxybutyric acid levels compared with control group. |
2-Oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
2-Oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) levels compared with control group. |
3-Hydroxymethylglutaric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
3-Hydroxymethylglutaric acid concentration: increase (Log2 FC=1.58) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 3-hydroxymethylglutaric acid levels compared with control group. |
7-Ketocholesterol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
7-Ketocholesterol concentration: decrease (Log2 FC=0.83) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 7-ketocholesterol levels compared with control group. |
Azelaic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Azelaic acid concentration: increase (Log2 FC=1.37) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of azelaic acid levels compared with control group. |
Cholesterol sulfate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Cholesterol sulfate concentration: increase (Log2 FC=1.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of cholesterol sulfate levels compared with control group. |
Glycerol 3-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glycerol 3-phosphate concentration: decrease (Log2 FC=0.52) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of glycerol 3-phosphate levels compared with control group. |
Glycerophosphocholine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glycerophosphocholine concentration: increase (Log2 FC=1.47) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of glycerophosphocholine levels compared with control group. |
Glycerophosphorylethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glycerophosphorylethanolamine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of glycerophosphorylethanolamine levels compared with control group. |
L-Acetylcarnitine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
L-Acetylcarnitine concentration: decrease (Log2 FC=0.73) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of L-acetylcarnitine levels compared with control group. |
L-alpha-Phosphatidylcholine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
L-alpha-Phosphatidylcholine concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of L-alpha-Phosphatidylcholine levels compared with control group. |
L-Palmitoylcarnitine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
L-Palmitoylcarnitine concentration: decrease (Log2 FC=0.33) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of L-palmitoylcarnitine levels compared with control group. |
Linoelaidic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Linoelaidic acid concentration: increase (Log2 FC=1.48) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of linoelaidic acid levels compared with control group. |
LysoPC(16:0/0:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
LysoPC(16:0/0:0) concentration: decrease (Log2 FC=0.42) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of lysoPC(16:0/0:0) levels compared with control group. |
LysoPC(18:1(9Z)) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
LysoPC(18:1(9Z)) concentration: decrease (Log2 FC=0.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of lysoPC(18:1(9Z)) levels compared with control group. |
LysoPC(22:0/0:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
LysoPC(22:0/0:0) concentration: decrease (Log2 FC=0.38) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of lysoPC(22:0/0:0) levels compared with control group. |
Mesaconic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Mesaconic acid concentration: increase (Log2 FC=1.09) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of mesaconic acid levels compared with control group. |
MG(14:0/0:0/0:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
MG(14:0/0:0/0:0) concentration: decrease (Log2 FC=0.39) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of MG(14:0/0:0/0:0) levels compared with control group. |
MG(16:0/0:0/0:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
MG(16:0/0:0/0:0) concentration: decrease (Log2 FC=0.27) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of MG(16:0/0:0/0:0) levels compared with control group. |
PC(16:0/16:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
PC(16:0/16:0) concentration: increase (Log2 FC=2.85) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of PC(16:0/16:0) levels compared with control group. |
PC(18:1(9Z)/18:1(9Z)) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
PC(18:1(9Z)/18:1(9Z)) concentration: increase (Log2 FC=1.41) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of PC(18:1(9Z)/18:1(9Z)) levels compared with control group. |
Platelet-activating factor |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Platelet-activating factor concentration: decrease (Log2 FC=0.33) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of platelet-activating factor levels compared with control group. |
Sphingomyelin (d18:0/16:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Sphingomyelin (d18:0/16:0) concentration: decrease (Log2 FC=0.93) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of sphingomyelin (d18:0/16:0) levels compared with control group. |
Stearoylcarnitine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Stearoylcarnitine concentration: decrease (Log2 FC=0.73) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of stearoylcarnitine levels compared with control group. |
Nucleosides/nucleotides |
2'-O-Methylinosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
2'-O-Methylinosine concentration: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 2'-o-Methylinosine levels compared with control group. |
Organic acids and derivatives |
(S)-2-Formylamino-4-methylsulfanylbutanoic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
(S)-2-Formylamino-4-methylsulfanylbutanoic acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of (S)-2-formylamino-4-methylsulfanylbutanoic acid levels compared with control group. |
2,4-Diaminobutyric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
2,4-Diaminobutyric acid concentration: decrease (Log2 FC=0.61) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 2,4-diaminobutyric acid levels compared with control group. |
2-Aminohexanedioic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
2-Aminohexanedioic acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 2-aminohexanedioic acid levels compared with control group. |
3-Hydroxydodecanoic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
3-Hydroxydodecanoic acid concentration: increase (Log2 FC=1.54) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 3-hydroxydodecanoic acid levels compared with control group. |
3-Methylhistidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
3-Methylhistidine concentration: decrease (Log2 FC=0.95) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 3-methylhistidine levels compared with control group. |
3-Nitrotyrosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
3-Nitrotyrosine concentration: increase (Log2 FC=1.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 3-nitrotyrosine levels compared with control group. |
4-Guanidinobutanoic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
4-Guanidinobutanoic acid concentration: increase (Log2 FC=1.51) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 4-guanidinobutanoic acid levels compared with control group. |
5-Aminopentanoic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
5-Aminopentanoic acid concentration: increase (Log2 FC=1.09) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 5-aminopentanoic acid levels compared with control group. |
Acamprosate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Acamprosate concentration: increase (Log2 FC=1.1) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of acamprosate levels compared with control group. |
Alanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Alanine concentration: increase (Log2 FC=1.01) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of alanine levels compared with control group. |
Alanylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Alanylglycine concentration: decrease (Log2 FC=0.89) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of alanylglycine levels compared with control group. |
Alpha-Ketoisovaleric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Alpha-Ketoisovaleric acid concentration: increase (Log2 FC=1.54) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of alpha-Ketoisovaleric acid levels compared with control group. |
Anserine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Anserine concentration: decrease (Log2 FC=0.59) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of anserine levels compared with control group. |
Arginine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Arginine concentration: decrease (Log2 FC=0.86) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of arginine levels compared with control group. |
Argininosuccinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Argininosuccinic acid concentration: decrease (Log2 FC=0.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of argininosuccinic acid levels compared with control group. |
Arginylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Arginylalanine concentration: increase (Log2 FC=1.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of arginylalanine levels compared with control group. |
Arginylaspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Arginylaspartic acid concentration: decrease (Log2 FC=0.81) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of arginylaspartic acid levels compared with control group. |
Arginylvaline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Arginylvaline concentration: increase (Log2 FC=1.17) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of arginylvaline levels compared with control group. |
Asparagine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Asparagine concentration: increase (Log2 FC=1.28) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of asparagine levels compared with control group. |
Aspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Aspartic acid concentration: decrease (Log2 FC=0.57) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of aspartic acid levels compared with control group. |
Asymmetric dimethylarginine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Asymmetric dimethylarginine concentration: decrease (Log2 FC=0.81) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of asymmetric dimethylarginine levels compared with control group. |
Betaine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Betaine concentration: increase (Log2 FC=1.81) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of betaine levels compared with control group. |
Carnosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Carnosine concentration: decrease (Log2 FC=0.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of carnosine levels compared with control group. |
Ciliatine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Ciliatine concentration: increase (Log2 FC=1.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of ciliatine levels compared with control group. |
cis-Aconitic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
cis-Aconitic acid concentration: increase (Log2 FC=1.18) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of cis-aconitic acid levels compared with control group. |
Citric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Citric acid concentration: increase (Log2 FC=1.28) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of citric acid levels compared with control group. |
Citrulline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Citrulline concentration: decrease (Log2 FC=0.78) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of citrulline levels compared with control group. |
Creatine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Creatine concentration: decrease (Log2 FC=0.62) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of creatine levels compared with control group. |
Creatinine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Creatinine concentration: decrease (Log2 FC=0.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of creatinine levels compared with control group. |
Cyclopropanecarboxylic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Cyclopropanecarboxylic acid concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of cyclopropanecarboxylic acid levels compared with control group. |
Cysteinylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Cysteinylglycine concentration: decrease (Log2 FC=0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of cysteinylglycine levels compared with control group. |
D-Aspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Aspartic acid concentration: increase (Log2 FC=1.19) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of D-aspartic acid levels compared with control group. |
D-Ornithine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Ornithine concentration: decrease (Log2 FC=0.68) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of D-Ornithine levels compared with control group. |
D-Pipecolic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Pipecolic acid concentration: increase (Log2 FC=1.22) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of D-Pipecolic acid levels compared with control group. |
D-Proline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Proline concentration: decrease (Log2 FC=0.57) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of D-Proline levels compared with control group. |
D-Serine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Serine concentration: decrease (Log2 FC=0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of D-Serine levels compared with control group. |
Edetic Acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Edetic Acid concentration: decrease (Log2 FC=0.19) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of edetic Acid levels compared with control group. |
Epsilon-(gamma-Glutamyl)lysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
epsilon-(gamma-Glutamyl)lysine concentration: decrease (Log2 FC=0.86) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of epsilon-(gamma-Glutamyl)lysine levels compared with control group. |
Folic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Folic acid concentration: increase (Log2 FC=1.03) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of folic acid levels compared with control group. |
Gamma-Aminobutyric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Gamma-Aminobutyric acid concentration: increase (Log2 FC=2.13) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of gamma-aminobutyric acid levels compared with control group. |
Gamma-Glutamylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Gamma-Glutamylalanine concentration: decrease (Log2 FC=0.9) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of gamma-glutamylalanine levels compared with control group. |
Gamma-Glutamylcysteine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Gamma-Glutamylcysteine concentration: decrease (Log2 FC=0.93) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of gamma-glutamylcysteine levels compared with control group. |
Gamma-Glutamylglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Gamma-Glutamylglutamic acid concentration: decrease (Log2 FC=0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of gamma-glutamylglutamic acid levels compared with control group. |
Gamma-Glutamylphenylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Gamma-Glutamylphenylalanine concentration: increase (Log2 FC=1.06) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of gamma-Glutamylphenylalanine levels compared with control group. |
Gamma-Glutamylvaline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Gamma-Glutamylvaline concentration: increase (Log2 FC=1.26) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of gamma-glutamylvaline levels compared with control group. |
Glutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glutamic acid concentration: decrease (Log2 FC=0.87) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of glutamic acid levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glutamic acid concentration: increase (Log2 FC=1.1) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of glutamic acid levels compared with control group. |
Glutamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glutamine concentration: decrease (Log2 FC=0.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of glutamine levels compared with control group. |
Glutamyllysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glutamyllysine concentration: decrease (Log2 FC=0.94) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of glutamyllysine levels compared with control group. |
Glutamylproline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glutamylproline concentration: increase (Log2 FC=1.09) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of glutamylproline levels compared with control group. |
Glycyl-Glutamate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glycyl-Glutamate concentration: decrease (Log2 FC=0.81) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of glycyl-glutamate levels compared with control group. |
Glycyl-Isoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glycyl-Isoleucine concentration: increase (Log2 FC=1.65) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of glycyl-Isoleucine levels compared with control group. |
Glycylproline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glycylproline concentration: decrease (Log2 FC=0.93) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of glycylproline levels compared with control group. |
Histidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Histidine concentration: increase (Log2 FC=1.14) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of histidine levels compared with control group. |
Histidylaspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Histidylaspartic acid concentration: decrease (Log2 FC=0.93) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of histidylaspartic acid levels compared with control group. |
Histidylglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Histidylglutamic acid concentration: increase (Log2 FC=1.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of histidylglutamic acid levels compared with control group. |
Histidylisoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Histidylisoleucine concentration: decrease (Log2 FC=0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of histidylisoleucine levels compared with control group. |
Histidylproline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Histidylproline concentration: decrease (Log2 FC=0.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of histidylproline levels compared with control group. |
Hypotaurine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Hypotaurine concentration: decrease (Log2 FC=0.7) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of hypotaurine levels compared with control group. |
Isoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Isoleucine concentration: decrease (Log2 FC=0.84) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of isoleucine levels compared with control group. |
Isoleucyl-Isoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Isoleucyl-Isoleucine concentration: increase (Log2 FC=1.07) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of isoleucyl-isoleucine levels compared with control group. |
Isoleucyl-Methionine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Isoleucyl-Methionine concentration: decrease (Log2 FC=0.7) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of isoleucyl-Methionine levels compared with control group. |
L-Targinine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
L-Targinine concentration: increase (Log2 FC=1.32) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of L-targinine levels compared with control group. |
Lactic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Lactic acid concentration: increase (Log2 FC=1.36) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of lactic acid levels compared with control group. |
Leucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Leucine concentration: decrease (Log2 FC=0.85) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of leucine levels compared with control group. |
Lysylaspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Lysylaspartic acid concentration: decrease (Log2 FC=0.63) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of lysylaspartic acid levels compared with control group. |
Lysylleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Lysylleucine concentration: decrease (Log2 FC=0.89) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of lysylleucine levels compared with control group. |
Lysylphenylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Lysylphenylalanine concentration: increase (Log2 FC=1.01) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of lysylphenylalanine levels compared with control group. |
Lysylserine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Lysylserine concentration: decrease (Log2 FC=0.99) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of lysylserine levels compared with control group. |
Lysylvaline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Lysylvaline concentration: increase (Log2 FC=1.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of lysylvaline levels compared with control group. |
Maleic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Maleic acid concentration: decrease (Log2 FC=0.86) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of maleic acid levels compared with control group. |
Malic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Malic acid concentration: increase (Log2 FC=1.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of malic acid levels compared with control group. |
Methionine |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Methionine concentration: decrease (Log2 FC=0.69) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of methionine levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Methionine concentration: increase (Log2 FC=2.87) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of methionine levels compared with control group. |
N(6)-Methyllysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N(6)-Methyllysine concentration: increase (Log2 FC=1.29) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of N(6)-methyllysine levels compared with control group. |
N-a-Acetyl-L-arginine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-a-Acetyl-L-arginine concentration: increase (Log2 FC=1.31) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of N-a-acetyl-L-arginine levels compared with control group. |
N-Acetyl-L-alanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetyl-L-alanine concentration: decrease (Log2 FC=0.68) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N-acetyl-L-alanine levels compared with control group. |
N-Acetyl-L-aspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetyl-L-aspartic acid concentration: decrease (Log2 FC=0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N-acetyl-L-aspartic acid levels compared with control group. |
N-Acetyl-L-glutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetyl-L-glutamic acid concentration: increase (Log2 FC=2.7) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of N-acetyl-L-glutamic acid levels compared with control group. |
N-Acetylaspartylglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetylaspartylglutamic acid concentration: increase (Log2 FC=1.06) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of N-acetylaspartylglutamic acid levels compared with control group. |
N-Acetylcadaverine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetylcadaverine concentration: decrease (Log2 FC=0.34) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylcadaverine levels compared with control group. |
N-Acetylglutamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetylglutamine concentration: decrease (Log2 FC=0.59) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylglutamine levels compared with control group. |
N-acetylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-acetylglycine concentration: decrease (Log2 FC=0.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylglycine levels compared with control group. |
N-Acetylputrescine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetylputrescine concentration: decrease (Log2 FC=0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylputrescine levels compared with control group. |
N6,N6,N6-Trimethyl-L-lysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N6,N6,N6-Trimethyl-L-lysine concentration: decrease (Log2 FC=0.83) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N6,N6,N6-Trimethyl-L-lysine levels compared with control group. |
N6-Acetyl-L-lysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N6-Acetyl-L-lysine concentration: decrease (Log2 FC=0.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N6-acetyl-L-lysine levels compared with control group. |
O-Phosphoethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
O-Phosphoethanolamine concentration: increase (Log2 FC=1) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of o-phosphoethanolamine levels compared with control group. |
Oxidized glutathione |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Oxidized glutathione concentration: decrease (Log2 FC=0.62) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of oxidized glutathione levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Oxidized glutathione concentration: increase (Log2 FC=1.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of oxidized glutathione levels compared with control group. |
Phenylacetylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phenylacetylglycine concentration: increase (Log2 FC=1.01) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of phenylacetylglycine levels compared with control group. |
Phenylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phenylalanine concentration: decrease (Log2 FC=0.8) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of phenylalanine levels compared with control group. |
Phenylalanylglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phenylalanylglutamic acid concentration: increase (Log2 FC=1.44) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of phenylalanylglutamic acid levels compared with control group. |
Phenylalanylproline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phenylalanylproline concentration: decrease (Log2 FC=0.67) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of phenylalanylproline levels compared with control group. |
Phenylalanylserine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phenylalanylserine concentration: increase (Log2 FC=1.1) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of phenylalanylserine levels compared with control group. |
Phenylalanylthreonine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phenylalanylthreonine concentration: increase (Log2 FC=7.37) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of phenylalanylthreonine levels compared with control group. |
Phosphocreatine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phosphocreatine concentration: decrease (Log2 FC=0.93) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of phosphocreatine levels compared with control group. |
Proline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Proline concentration: decrease (Log2 FC=0.92) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of proline levels compared with control group. |
Prolyl-Alanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolyl-Alanine concentration: decrease (Log2 FC=0.93) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-alanine levels compared with control group. |
Prolyl-Arginine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolyl-Arginine concentration: increase (Log2 FC=1.29) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of prolyl-arginine levels compared with control group. |
Prolyl-Asparagine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolyl-Asparagine concentration: increase (Log2 FC=1.27) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of prolyl-asparagine levels compared with control group. |
Prolyl-Aspartate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolyl-Aspartate concentration: decrease (Log2 FC=0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-aspartate levels compared with control group. |
Prolyl-Glutamate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolyl-Glutamate concentration: decrease (Log2 FC=0.97) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-glutamate levels compared with control group. |
Prolyl-Methionine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolyl-Methionine concentration: decrease (Log2 FC=0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-methionine levels compared with control group. |
Prolyl-Serine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolyl-Serine concentration: decrease (Log2 FC=0.88) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-serine levels compared with control group. |
Prolyl-Valine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolyl-Valine concentration: increase (Log2 FC=1.1) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of prolyl-valine levels compared with control group. |
Prolylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolylglycine concentration: increase (Log2 FC=1.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of prolylglycine levels compared with control group. |
Prolylphenylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Prolylphenylalanine concentration: decrease (Log2 FC=0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of prolylphenylalanine levels compared with control group. |
Pyroglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Pyroglutamic acid concentration: decrease (Log2 FC=0.5) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of pyroglutamic acid levels compared with control group. |
S-Lactoylglutathione |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
S-Lactoylglutathione concentration: increase (Log2 FC=1.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of s-lactoylglutathione levels compared with control group. |
Saccharopine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Saccharopine concentration: decrease (Log2 FC=0.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of saccharopine levels compared with control group. |
Sarcosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Sarcosine concentration: decrease (Log2 FC=0.73) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of sarcosine levels compared with control group. |
Serine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Serine concentration: increase (Log2 FC=1.27) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of serine levels compared with control group. |
Succinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Succinic acid concentration: increase (Log2 FC=1.03) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of succinic acid levels compared with control group. |
Taurine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Taurine concentration: decrease (Log2 FC=0.6) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of taurine levels compared with control group. |
Threonine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Threonine concentration: decrease (Log2 FC=0.66) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of threonine levels compared with control group. |
Threonylaspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Threonylaspartic acid concentration: decrease (Log2 FC=0.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of threonylaspartic acid levels compared with control group. |
Tyrosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Tyrosine concentration: decrease (Log2 FC=0.8) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of tyrosine levels compared with control group. |
Valine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Valine concentration: decrease (Log2 FC=0.89) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of valine levels compared with control group. |
Valylisoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Valylisoleucine concentration: decrease (Log2 FC=0.7) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of valylisoleucine levels compared with control group. |
Organic nitrogen compounds |
Acetylcholine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Acetylcholine concentration: decrease (Log2 FC=0.8) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of acetylcholine levels compared with control group. |
Betaine aldehyde |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Betaine aldehyde concentration: increase (Log2 FC=1.44) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of betaine aldehyde levels compared with control group. |
Carnitine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Carnitine concentration: decrease (Log2 FC=0.92) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of carnitine levels compared with control group. |
Cyclohexylammonium |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Cyclohexylammonium concentration: decrease (Log2 FC=0.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of cyclohexylammonium levels compared with control group. |
Diethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Diethanolamine concentration: decrease (Log2 FC=0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of diethanolamine levels compared with control group. |
Oleoylethanolamide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Oleoylethanolamide concentration: decrease (Log2 FC=0.66) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of oleoylethanolamide levels compared with control group. |
Phosphorylcholine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phosphorylcholine concentration: increase (Log2 FC=1.26) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of phosphorylcholine levels compared with control group. |
Triethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Triethanolamine concentration: decrease (Log2 FC=0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of triethanolamine levels compared with control group. |
Organic oxygen compounds |
1-Deoxy-D-xylulose 5-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
1-Deoxy-D-xylulose 5-phosphate concentration: increase (Log2 FC=1.43) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 1-deoxy-D-xylulose 5-phosphate levels compared with control group. |
3-Phosphoglyceric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
3-Phosphoglyceric acid concentration: increase (Log2 FC=1.29) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 3-phosphoglyceric acid levels compared with control group. |
Acetyl-CoA |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Acetyl-CoA concentration: decrease (Log2 FC=0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of acetyl-CoA levels compared with control group. |
D-Erythrose 4-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Erythrose 4-phosphate concentration: increase (Log2 FC=1.23) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of D-erythrose 4-phosphate levels compared with control group. |
D-Mannose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Mannose concentration: decrease (Log2 FC=0.87) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of D-Mannose levels compared with control group. |
D-Ribose 5-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Ribose 5-phosphate concentration: increase (Log2 FC=1.84) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of D-Ribose 5-phosphate levels compared with control group. |
D-Threitol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Threitol concentration: decrease (Log2 FC=0.97) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of D-threitol levels compared with control group. |
D-Xylitol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
D-Xylitol concentration: decrease (Log2 FC=0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of D-xylitol levels compared with control group. |
Deoxyribose 5-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Deoxyribose 5-phosphate concentration: increase (Log2 FC=1.07) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of deoxyribose 5-phosphate levels compared with control group. |
Dihydroxyacetone phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Dihydroxyacetone phosphate concentration: increase (Log2 FC=3.12) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of dihydroxyacetone phosphate levels compared with control group. |
Fucose 1-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Fucose 1-phosphate concentration: increase (Log2 FC=1.03) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of fucose 1-phosphate levels compared with control group. |
Galactinol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Galactinol concentration: decrease (Log2 FC=0.25) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of galactinol levels compared with control group. |
Galactose 1-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Galactose 1-phosphate concentration: decrease (Log2 FC=0.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of galactose 1-phosphate levels compared with control group. |
Galacturonic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Galacturonic acid concentration: decrease (Log2 FC=0.95) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of galacturonic acid levels compared with control group. |
Glucosamine 6-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glucosamine 6-phosphate concentration: decrease (Log2 FC=0.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of glucosamine 6-phosphate levels compared with control group. |
Glucose 1-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glucose 1-phosphate concentration: increase (Log2 FC=1.21) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of glucose 1-phosphate levels compared with control group. |
Glutaral |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Glutaral concentration: decrease (Log2 FC=0.77) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of glutaral levels compared with control group. |
Isomaltose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Isomaltose concentration: decrease (Log2 FC=0.48) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of isomaltose levels compared with control group. |
Maltotriose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Maltotriose concentration: increase (Log2 FC=1.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of maltotriose levels compared with control group. |
myo-Inositol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
myo-Inositol concentration: increase (Log2 FC=1.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of myo-inositol levels compared with control group. |
N-Acetyl-D-Glucosamine 6-Phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetyl-D-Glucosamine 6-Phosphate concentration: increase (Log2 FC=1.51) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of N-acetyl-D-glucosamine 6-phosphate levels compared with control group. |
N-Acetyl-glucosamine 1-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetyl-glucosamine 1-phosphate concentration: decrease (Log2 FC=0.65) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N-acetyl-glucosamine 1-phosphate levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetyl-glucosamine 1-phosphate concentration: increase (Log2 FC=1.53) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of N-acetyl-glucosamine 1-phosphate levels compared with control group. |
N-Acetylmannosamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetylmannosamine concentration: decrease (Log2 FC=0.96) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylmannosamine levels compared with control group. |
N-Acetylneuraminic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetylneuraminic acid concentration: decrease (Log2 FC=0.66) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylneuraminic acid levels compared with control group. |
Pantothenic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Pantothenic acid concentration: decrease (Log2 FC=0.59) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of pantothenic acid levels compared with control group. |
Pectin |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Pectin concentration: decrease (Log2 FC=0.52) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of pectin levels compared with control group. |
Pyruvaldehyde |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Pyruvaldehyde concentration: decrease (Log2 FC=0.9) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of pyruvaldehyde levels compared with control group. |
Trehalose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Trehalose concentration: decrease (Log2 FC=0.26) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of trehalose levels compared with control group. |
Organo heterocyclic compounds |
L-beta-Homoproline hydrochloride |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
L-beta-Homoproline hydrochloride concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of L-beta-Homoproline hydrochloride levels compared with control group. |
Methyl 5-amino-4-carbamoyl-imidazole-1-carboxylate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
methyl 5-amino-4-carbamoyl-imidazole-1-carboxylate concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of methyl 5-amino-4-carbamoyl-imidazole-1-carboxylate levels compared with control group. |
Organoheterocyclic compounds |
2-Hydroxyadenine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
2-Hydroxyadenine concentration: increase (Log2 FC=7.58) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of 2-hydroxyadenine levels compared with control group. |
2-Hydroxypyridine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
2-Hydroxypyridine concentration: decrease (Log2 FC=0.54) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 2-hydroxypyridine levels compared with control group. |
3-Hydrazono-1-methyl-1,3-dihydro-indol-2-one |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
3-Hydrazono-1-methyl-1,3-dihydro-indol-2-one concentration: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 3-hydrazono-1-methyl-1,3-dihydro-indol-2-one levels compared with control group. |
Biopterin |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Biopterin concentration: decrease (Log2 FC=0.61) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of biopterin levels compared with control group. |
Caffeine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Caffeine concentration: increase (Log2 FC=5.84) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of caffeine levels compared with control group. |
Cytosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Cytosine concentration: increase (Log2 FC=1.24) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of cytosine levels compared with control group. |
Dihydrothymine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Dihydrothymine concentration: decrease (Log2 FC=0.61) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of dihydrothymine levels compared with control group. |
Dihydrouracil |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Dihydrouracil concentration: decrease (Log2 FC=0.8) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of dihydrouracil levels compared with control group. |
Folinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Folinic acid concentration: decrease (Log2 FC=0.86) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of folinic acid levels compared with control group. |
Gamma-Butyrolactone |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Gamma-Butyrolactone concentration: increase (Log2 FC=1.3) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of gamma-Butyrolactone levels compared with control group. |
Hypoxanthine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Hypoxanthine concentration: increase (Log2 FC=8.31) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of hypoxanthine levels compared with control group. |
Imidazoleacetic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Imidazoleacetic acid concentration: increase (Log2 FC=1.09) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of imidazoleacetic acid levels compared with control group. |
Indole |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Indole concentration: increase (Log2 FC=1.15) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of indole levels compared with control group. |
Indolelactic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Indolelactic acid concentration: increase (Log2 FC=2.45) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of indolelactic acid levels compared with control group. |
N-Acetylserotonin |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
N-Acetylserotonin concentration: increase (Log2 FC=1.13) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of N-acetylserotonin levels compared with control group. |
Niacinamide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Niacinamide concentration: decrease (Log2 FC=0.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of niacinamide levels compared with control group. |
Oxypurinol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Oxypurinol concentration: increase (Log2 FC=3.21) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of oxypurinol levels compared with control group. |
Pyridoxal |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Pyridoxal concentration: decrease (Log2 FC=0.65) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of pyridoxal levels compared with control group. |
Pyridoxine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Pyridoxine concentration: decrease (Log2 FC=0.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of pyridoxine levels compared with control group. |
Quinaldine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Quinaldine concentration: increase (Log2 FC=1.89) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of quinaldine levels compared with control group. |
Thiamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Thiamine concentration: decrease (Log2 FC=0.93) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of thiamine levels compared with control group. |
Thymine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Thymine concentration: increase (Log2 FC=1.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of thymine levels compared with control group. |
Tryptophan |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Tryptophan concentration: decrease (Log2 FC=0.66) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of tryptophan levels compared with control group. |
Tryptophol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Tryptophol concentration: decrease (Log2 FC=0.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of tryptophol levels compared with control group. |
Uracil |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Uracil concentration: decrease (Log2 FC=0.5) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of uracil levels compared with control group. |
Uric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Uric acid concentration: increase (Log2 FC=1.11) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of uric acid levels compared with control group. |
Uridine diphosphate glucuronic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Uridine diphosphate glucuronic acid concentration: increase (Log2 FC=1.33) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of uridine diphosphate glucuronic acid levels compared with control group. |
Urocanic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Urocanic acid concentration: decrease (Log2 FC=0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of urocanic acid levels compared with control group. |
Xanthine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Xanthine concentration: increase (Log2 FC=4.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of xanthine levels compared with control group. |
Phenylpropanoids and polyketides |
4-Hydroxycinnamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
4-Hydroxycinnamic acid concentration: decrease (Log2 FC=0.8) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of 4-hydroxycinnamic acid levels compared with control group. |
Hydroxyphenyllactic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Hydroxyphenyllactic acid concentration: increase (Log2 FC=1.33) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of hydroxyphenyllactic acid levels compared with control group. |
Mulberrofuran M |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Mulberrofuran M concentration: increase (Log2 FC=1.38) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the increase of mulberrofuran M levels compared with control group. |
Phenyllactic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Metabo Info
click to show the details of this metabolite
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Knockout of TP53 |
Induced Change |
Phenyllactic acid concentration: decrease (Log2 FC=0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that knockout of TP53 leads to the decrease of phenyllactic acid levels compared with control group. |
|
|
|
|
|
|
|